A glucosylceramide synthase inhibitor protects rats against the cytotoxic effects of shiga toxin 2. (Q33393854)

26 July 2017

title

A glucosylceramide synthase inhibitor protects rats against the cytotoxic effects of shiga toxin 2. (English)

1 reference

26 July 2017

Elsa Zotta

3

0 references

Diane P Copeland

4

object named as

Diane P Copeland

1 reference

26 July 2017

Claudia Silberstein

1

1 reference

26 July 2017

María S Lucero

2

1 reference

26 July 2017

Li Lingyun

5

1 reference

26 July 2017

Horacio A Repetto

6

1 reference

26 July 2017

Cristina Ibarra

7

1 reference

26 July 2017

language of work or name

English

0 references

publication date

1 May 2011

1 reference

26 July 2017

1 reference

26 July 2017

volume

69

1 reference

26 July 2017

issue

5 Pt 1

1 reference

26 July 2017

page(s)

390-394

1 reference

Epidemic hemolytic-uremic syndrome in children

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E318211DD57

Long-term course and mechanisms of progression of renal disease in hemolytic uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E318211DD57

THE HEMOLYTIC-UREMIC SYNDROME.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E318211DD57

Role of verotoxin receptors in pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E318211DD57

Differential tissue targeting and pathogenesis of verotoxins 1 and 2 in the mouse animal model

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E318211DD57

Targeted disruption of Gb3/CD77 synthase gene resulted in the complete deletion of globo-series glycosphingolipids and loss of sensitivity to verotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E318211DD57

Cytotoxic effect of Shiga toxin-2 holotoxin and its B subunit on human renal tubular epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E318211DD57

The detection of Shiga toxins in the kidney of a patient with hemolytic uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E318211DD57

Inhibition of water absorption in human proximal tubular epithelial cells in response to Shiga toxin-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E318211DD57

The Shiga toxin 2 B subunit inhibits net fluid absorption in human colon and elicits fluid accumulation in rat colon loops.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E318211DD57

Combinatorial ganglioside biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E318211DD57

Reduction of globotriaosylceramide in Fabry disease mice by substrate deprivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E318211DD57

Intracerebroventricular administration of Shiga toxin type 2 induces striatal neuronal death and glial alterations: an ultrastructural study

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E318211DD57

Therapeutic strategies for Shiga toxin-producing Escherichia coli infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E318211DD57

Oral administration of formaldehyde-killed recombinant bacteria expressing a mimic of the Shiga toxin receptor protects mice from fatal challenge with Shiga-toxigenic Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E318211DD57

Effect of an oral Shiga toxin-binding agent on diarrhea-associated hemolytic uremic syndrome in children: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E318211DD57

Monovalent Gb3-/Gb2-derivatives conjugated with a phosphatidyl residue: a novel class of Shiga toxin-neutralizing agent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E318211DD57

Protection against Shiga toxin 1 challenge by immunization of mice with purified mutant Shiga toxin 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E318211DD57

Development of DNA vaccines against hemolytic-uremic syndrome in a murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E318211DD57

A nasal vaccine comprising B-subunit derivative of Shiga toxin 2 for cross-protection against Shiga toxin types 1 and 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E318211DD57

Development of an experimental hemolytic uremic syndrome in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E318211DD57

Intracerebroventricular Shiga toxin 2 increases the expression of its receptor globotriaosylceramide and causes dendritic abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E318211DD57

Pathogenesis of Shiga toxin-induced hemolytic uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E318211DD57

Human intestinal tissue and cultured colonic cells contain globotriaosylceramide synthase mRNA and the alternate Shiga toxin receptor globotetraosylceramide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E318211DD57

Inhibition of glycolipid biosynthesis by N-(5-adamantane-1-yl-methoxy-pentyl)-deoxynojirimycin protects against the inflammatory response in hapten-induced colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E318211DD57

Interaction of Shiga toxin from Escherichia coli with human intestinal epithelial cell lines and explants: Stx2 induces epithelial damage in organ culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E318211DD57

Improved Inhibitors of Glucosylceramide Synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E318211DD57

10.1203/PDR.0B013E318211DD57

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

26 July 2017

1019458166

0 references

1 reference